知镜 Cognispect · 医学文献与研究工作台

Impact of Severe COVID-19 on Interstitial Lung Disease in Autoimmune Systemic Diseases.

Ferri C, de Pinto M, Murdaca G, De Luca G, Beigi DMR, Caira V, Foti R, Cito A, Naclerio C, Luppino JME, Spinella A, Orlandi M, Batani V, Lumetti F, Prampolini F, Varcasia G, Foti R, Riccieri V, Iannone F, Antonelli A, Giuggioli D, COVID‐19 and Autoimmune Systemic Diseases Italian Study Group.
Respirology case reports · 2026-09-22 · PMID 42780678

文献摘要

The objective of this study was to assess the impact of severe COVID-19 pneumonia on the course of interstitial lung disease (ILD) in autoimmune systemic diseases (ASD). We conducted a multicentre case series of 27 ASD patients (20 systemic sclerosis, 4 rheumatoid arthritis, 1 interstitial pneumonia with autoimmune features, 1 dermatomyositis, 1 eosinophilic granulomatosis with polyangiitis) hospitalised for severe COVID-19. Clinical data, pulmonary function tests and HRCT before and after infection were analysed. Four patients died during acute COVID-19. Among the 23 survivors, 10 developed new symptomatic ILD and 13 showed worsening of pre-existing ILD. Six exhibited significant HRCT progression, including NSIP-to-UIP transition; one developed lung adenocarcinoma. Despite treatment, five more patients died during follow-up from progressive ILD. Overall mortality approached one-third, with systemic sclerosis most affected. Severe COVID-19 may trigger or accelerate ASD-related ILD. The observed NSIP-to-UIP shift highlights a multistep process potentially driven by SARS-CoV-2, underscoring the need for close ILD monitoring in ASD patients.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。